Rhumbline Advisers Fibrogen Inc Transaction History

Rhumbline Advisers

  • $105 Billion
  • Q2 2024

A detailed history of Rhumbline Advisers transactions in Fibrogen Inc stock. As of the latest transaction made, Rhumbline Advisers holds 59,141 shares of FGEN stock, worth $27,796. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,141
Previous 157,240 62.39%
Holding current value
$27,796
Previous $369,000 85.91%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
SELL
$0.89 - $2.36 $87,308 - $231,513
-98,099 Reduced 62.39%
59,141 $52,000
Q1 2024

May 09, 2024
BUY
$0.73 - $2.73 $1,954 - $7,308
2,677 Added 1.73%
157,240 $369,000
Q4 2023

Feb 08, 2024
SELL
$0.38 - $0.91 $9 - $21
-24 Reduced 0.02%
154,563 $137,000
Q3 2023

Nov 09, 2023
SELL
$0.79 - $2.83 $6,954 - $24,912
-8,803 Reduced 5.39%
154,587 $132,000
Q2 2023

Aug 08, 2023
BUY
$2.49 - $20.59 $75,656 - $625,606
30,384 Added 22.84%
163,390 $441,000
Q1 2023

May 11, 2023
BUY
$15.95 - $25.18 $82,684 - $130,533
5,184 Added 4.06%
133,006 $2.48 Million
Q4 2022

Feb 14, 2023
BUY
$13.27 - $17.73 $36,532 - $48,810
2,753 Added 2.2%
127,822 $2.05 Million
Q3 2022

Nov 10, 2022
BUY
$11.4 - $14.6 $140,698 - $180,193
12,342 Added 10.95%
125,069 $1.63 Million
Q2 2022

Aug 11, 2022
BUY
$7.94 - $12.96 $103,140 - $168,350
12,990 Added 13.02%
112,727 $1.19 Million
Q1 2022

May 12, 2022
SELL
$12.02 - $16.79 $53,164 - $74,262
-4,423 Reduced 4.25%
99,737 $1.2 Million
Q4 2021

Feb 10, 2022
BUY
$9.93 - $15.39 $4,091 - $6,340
412 Added 0.4%
104,160 $1.47 Million
Q3 2021

Nov 12, 2021
SELL
$10.18 - $26.64 $28,290 - $74,032
-2,779 Reduced 2.61%
103,748 $1.06 Million
Q2 2021

Aug 05, 2021
BUY
$18.57 - $35.68 $99,758 - $191,672
5,372 Added 5.31%
106,527 $2.84 Million
Q1 2021

May 06, 2021
SELL
$31.0 - $55.72 $343,449 - $617,321
-11,079 Reduced 9.87%
101,155 $3.51 Million
Q4 2020

Feb 10, 2021
SELL
$37.09 - $48.97 $101,515 - $134,030
-2,737 Reduced 2.38%
112,234 $4.16 Million
Q3 2020

Nov 12, 2020
SELL
$40.47 - $45.5 $1.17 Million - $1.32 Million
-28,936 Reduced 20.11%
114,971 $4.73 Million
Q2 2020

Aug 13, 2020
BUY
$32.57 - $42.83 $591,438 - $777,749
18,159 Added 14.44%
143,907 $5.83 Million
Q1 2020

May 06, 2020
SELL
$23.3 - $45.96 $12,954 - $25,553
-556 Reduced 0.44%
125,748 $4.37 Million
Q4 2019

Feb 05, 2020
BUY
$34.58 - $48.06 $184,726 - $256,736
5,342 Added 4.42%
126,304 $5.42 Million
Q3 2019

Oct 23, 2019
SELL
$36.98 - $48.45 $84,721 - $110,998
-2,291 Reduced 1.86%
120,962 $4.47 Million
Q2 2019

Aug 14, 2019
BUY
$35.13 - $55.53 $445,799 - $704,675
12,690 Added 11.48%
123,253 $5.57 Million
Q1 2019

May 01, 2019
SELL
$42.83 - $59.91 $48,697 - $68,117
-1,137 Reduced 1.02%
110,563 $6.01 Million
Q4 2018

Jan 31, 2019
BUY
$37.97 - $60.16 $1.51 Million - $2.4 Million
39,812 Added 55.38%
111,700 $5.17 Million
Q3 2018

Nov 07, 2018
SELL
$56.3 - $67.25 $426,359 - $509,284
-7,573 Reduced 9.53%
71,888 $4.37 Million
Q2 2018

Aug 06, 2018
BUY
$44.9 - $64.95 $419,141 - $606,308
9,335 Added 13.31%
79,461 $4.97 Million
Q1 2018

May 02, 2018
SELL
$45.35 - $61.65 $16,416 - $22,317
-362 Reduced 0.51%
70,126 $3.24 Million
Q4 2017

Feb 09, 2018
SELL
$41.95 - $60.1 $462,834 - $663,083
-11,033 Reduced 13.53%
70,488 $3.34 Million
Q3 2017

Nov 06, 2017
BUY
$33.4 - $53.9 $2.72 Million - $4.39 Million
81,521
81,521 $4.39 Million

Others Institutions Holding FGEN

# of Institutions
115
Shares Held
57.5M
Call Options Held
2.14M
Put Options Held
907K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $44.1M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email